The 30-scrip Sensitive Index (Sensex) of the BSE closed at 32,400.51 points - down 1.86 points, or 0.01 per cent, from its previous close at 32,402.37 points. During the day, it touched a high of 32,508.06. It rose 17.75 points or 0.17% at the day's high of 10,158.90 in early trade.
Shares of Dr. Reddy's Laboratories advanced 7.5% to close at Rs 2,486.5 on Thursday after the drugmaker received an EIR (Establishment Inspection Report) from the United States food and drug regulator for it's Srikakulam plant.
Small-cap and mid-cap stocks moved in tandem with the benchmark indices, weakening by up to 0.51 per cent. Strides Shasun (down 1.83%) declined. Pharma companies derive substantial revenue from exports.
The domestic currency opened weak by 25 paise at 64.52 at the Interbank Foreign Exchange market today.
But Dr Reddy's Laboratories surged over 7.7 percent after the drugmaker said it got establishment inspection report from US drug regulator for its Srikakulam plant.
On Thursday, Asian indices were mostly showing a positive trend.
Separately, Dr Reddy's Laboratories said that it has received an Establishment Inspection Report from the USA drug regulator, for its Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh.
The Bank of Japan (BOJ), at the conclusion of its two-day monetary policy meeting today, 21 September 2017, kept monetary policy steady.
The central bank is widely expected to leave interest rates untouched. The decision was made by an eight-to-one vote. The Sensex fell 236 points intraday due to sharp depreciation in rupee post Federal Reserve hinted rate hike by December and announced unwinding of balance sheet, but recovered over 200 points in later part of session. As expected, the Fed said it would begin reducing in October its approximately $4.2 trillion in holdings of U.S. treasury bonds and mortgage-backed securities by initially cutting up to $10 billion each month from the amount of maturing securities it reinvests, reported Bloomberg.